Tetrahymena thermophila is a eucaryotic organism that is highly susceptible to growth inhibition by aminoglycoside antibiotics. Concentrations of paromomycin, gentamicin G418, and hygromycin B at 22, 10, and 17 ,uM, respectively, inhibited growth by 50%. A combination of in vitro and in vivo methods was used to determine the mechanisms of action of these aminoglycoside antibiotics on protein synthesis in T. thermophila. Analysis of polysome profiles from paromomycin-and gentamicin G418-treated cells showed clear, progressive depletions of polysomes concomitant with an inhibition of in vivo [14C]lysine incorporation. In vitro, paromomycin and gentamicin G418, which are disubstituted 2-deoxystreptamine-containing molecules, were not very effective inhibitors of either the translocation of peptidyl-tRNA or the elongation of nascent polypeptide chains on polysomes. In contrast, we found that the translocation of phe-tRNA on polyuridylate programmed ribosomes was susceptible to inhibition by paromomycin. We conclude that the primary inhibitory action of paromomycin and gentamicin G418 was at (i) an early stage of elongation after initiation, (ii) the initiation stage of translation, or (iii) a stage of translation before initiation. Hygromycin B, which is a monosubstituted 2-deoxystreptamine-containing aminoglycoside, potently inhibited the elongation of nascent chains during the translation of polysomes. In addition, the in vitro translation of polysomes from two hygromycin B-resistant mutants was resistant to the inhibition of elongation caused by hygromycin B.Aminoglycoside antibiotics are well-established inhibitors of growth, stimulators of misreading, and inhibitors of protein synthesis in procaryotes and eucaryotes (18). Vazquez and co-workers have studied the in vitro activities of many aminoglycoside antibiotics in eucaryotic model systems derived from yeasts and mammalian cells (20 and references therein). Of the aminoglycoside antibiotics tested, those active in inhibiting protein synthesis were usually found to inhibit the polypeptide chain elongation phase (20). Model systems to study the interaction of antibiotics with the ribosome at separate stages of the elongation cycle have proven to be powerful tools in the elucidation of antibiotic action on ribosomes. Furthermore, these studies have greatly enhanced the understanding of the structure-function relationships of ribosomes (8,15).Eucaryotic protein synthesis has not, however, received as much attention as have procaryotic systems, and the majority of current concepts about the structure of eucaryotic ribosomes have been derived by analogy with the extensive information available from Escherichia coli ribosomes. Model systems derived from different eucaryotic sources do not have uniform responses to a particular aminoglycoside, as is exemplified by the failure of paromomycin (PM) to inhibit the cytoplasmic protein synthesis of yeasts (14), mammalian cells (21), and wheat germ (22). In contrast, cytoplasmic protein synthesis in the lower eucaryote Tet...